Hartej Gill
Researcher in mood disorders psychopharmacology at the University of Toronto / University Health Network
Papers
Trials
Key Impact
Notable for coauthoring multiple reviews and meta-analyses on ketamine, esketamine, suicidality, cognition, and psychedelic drug trials in psychiatric research.
Background & Research
Hartej Gill is a researcher associated with the Mood Disorders Psychopharmacology Unit at the University Health Network and the University of Toronto in Toronto, Canada. Their publications include systematic reviews and meta-analyses on ketamine’s antidepressant, antisuicidal, and cognitive effects, as well as work on registered clinical studies of psychedelic drugs for psychiatric disorders. Recent article listings identify Gill as a corresponding author on this research program.
Collaboration Network
18 collaborators· click a node to visit their profile
Full network →